Cantor Fitzgerald, L. P. »

BioCryst Pharmaceuticals shares owned by Cantor Fitzgerald, L. P.

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Cantor Fitzgerald, L. P. from 13F filings

Historical chart of Cantor Fitzgerald, L. P. investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Cantor Fitzgerald, L. P. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Cantor Fitzgerald, L. P.

Quarter filed Position value Share count Share price at filing
2025-09-30 $807k 106k 7.59
2025-06-30 $639k 71k 8.96

More positions owned by Cantor Fitzgerald, L. P.

Strategy Cl A (MSTR)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Advanced Micro Devices (AMD)
Tesla Motors (TSLA)
Robinhood Mkts Com Cl A (HOOD)
Super Micro Computer Inc Com Usd0.001 (SMCI)
UnitedHealth (UNH)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Rocket Lab Corp (RKLB)
Fidelity Wise Origin Bitcoin SHS (FBTC)
Oracle Corporation (ORCL)
Oklo Com Cl A (OKLO)
Broadcom (AVGO)
Rigetti Computing Common Stock (RGTI)

View all positions for Cantor Fitzgerald, L. P.

Top funds holding BioCryst Pharmaceuticals

Vanguard Group
BlackRock
Deerfield Management Company
State Street Corporation
Kynam Capital Management
Alkeon Capital Management
UBS Group
Arrowstreet Capital, Limited Partnership
Geode Capital Management
Two Sigma Investments
Two Sigma Advisers
Hood River Capital Management
Nuveen
Goldman Sachs Group
Jane Street

View all funds holding BioCryst Pharmaceuticals